Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| DDC-H55H6 | Human | Human DDC / Dopa Decarboxilase Protein, His Tag (MALS verified) |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Benserazide Hydrochloride | Approved | Mainland China | Parkinson Disease; Dyskinesias | Shanghai Yishengyuan Pharmaceutical Co Ltd | 1995-01-01 | Dyskinesias; Parkinson Disease | Details | |||
| Carbidopa | MK-486 | Approved | Lodosyn | Mainland China | Parkinson Disease | Nantong Jinghua Pharmaceutical Co Ltd | 1977-04-25 | Postural Orthostatic Tachycardia Syndrome; Parkinson Disease; Orthostatic Intolerance | Details | |
| Carbidopa/Entacapone/Levodopa | ODM-101; ELC-200 | Approved | Orion Pharma | Trigel, LECIGel, 达灵复, Stalevo, LECIGon | Japan | Parkinson Disease | Novartis Pharma Ag | 2003-06-11 | Parkinson Disease | Details |
| Levodopa/Carbidopa | IPX-054; AP-09004; DM-1992; AP-CDLD; TPI-926; IPX-066; ABT-SLV-187; AP-CD/LD; ND-0612; ND-0680; ND-0612L; ND-0612H; PW-4153; LCIG; ABT-SLV187; IPX-203; CP-012; JM-012; SOL-707; INP-107(POD™ carbidopa/levodopa) | Approved | Merck Sharp & Dohme Corp | Nacom (imciromab), Nacom retard, Parcopa, Patrome, DopaFuse, Sinemet, Numient, Menesit, Duodopa, Vadova, Rytary, Isicom, Duopa | Mainland China | Parkinson Disease | Jinghua Pharmaceutical Group Co Ltd | 1975-05-02 | Amblyopia; Amyotrophic Lateral Sclerosis; Diabetic Retinopathy; Diabetes Mellitus; Albinism; Cocaine-Related Disorders; Cognitive Dysfunction; Depressive Disorder, Treatment-Resistant; Albinism, Oculocutaneous; Gait Apraxia; Parkinson Disease; Aphasia, Broca; Stroke; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Depression; Motor Neuron Disease | Details |
| Eladocagene exuparvovec | PTC-AADC | Approved | National Taiwan University, Ptc Therapeutics Inc | Upstaza | United Kingdom | Aromatic amino acid decarboxylase deficiency | Ptc Therapeutics Inc | 2022-07-18 | Aromatic amino acid decarboxylase deficiency; Amino Acid Metabolism, Inborn Errors | Details |
| Carbidopa/Melevodopa | V-1512; GT-1512; CHF-1512; CNP-1512 | Approved | Chiesi Farmaceutici SPA | Sirio | Italy | Parkinson Disease | null | 2003-01-01 | Parkinson Disease | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Buspirone/Carbidopa/Levodopa | Phase 2 Clinical | Universite Laval | Spinal Cord Injuries; Multiple Sclerosis | Details | |
| Levodopa/Carbidopa controlled release tablets-night(WD Pharmaceutical) | WD-1905 | Phase 2 Clinical | Parkinsonian Disorders | Details | |
| Levodopa/Carbidopa controlled release tablets(WD Pharmaceutical) | WD-1603 | Phase 2 Clinical | Parkinsonian Disorders | Details | |
| Levodopa/Carbidopa(WD Pharmaceutical) | WD-1804 | Phase 1 Clinical | Parkinsonian Disorders | Details | |
| Levodopa/Carbidopa granule(WD Pharmaceutical) | WD-2010 | Phase 1 Clinical | Parkinsonian Disorders | Details | |
| Ezaladcigene resoparvovec | GZ-404477; AV-201; VY-AADC02; VY-AADC; VY-AADC01 | Phase 1 Clinical | University Of California, Voyager Therapeutics Inc | Aromatic amino acid decarboxylase deficiency; Parkinson Disease | Details |
This web search service is supported by Google Inc.
A-Z
